Ozempic and Wegovy Are Fueling Novo Nordisk's Business, but Something Else May Be an Even Bigger Growth Driver in the Long Run
Novo-Nordisk A/S · Now $44.07
+2.8% in 7d after detection
Post-detection moves
1h
—
1d
0.0%
3d
+0.2%
7d
+2.8%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS